Records containing: SARS-CoV-2 Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-05-20A Phase 1, Open-Label, Randomized Study to Evaluate Safety and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin (Human) Investigational Product (COVID-HIG) Administered Through Intramuscular, Subcutaneous or Intravenous Routes as a Single Dose Regimen to SARS-CoV-2 Uninfected Adults
-
CLINICAL_TRIALS study record update · 2024-05-08SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonia - Brussels: An Epidemiological Pilot Study
-
CLINICAL_TRIALS study record update · 2024-04-30IVD_ Starfish_Clinical Performance Study Protocol for US - Project STARFISH - PRJ0002679
-
CLINICAL_TRIALS study record update · 2024-04-25A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster in People Aged 18-60 Years
-
CLINICAL_TRIALS study record update · 2024-04-24Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster Following Primary Vaccination of Either Inactivated or mRNA or Viral Vector COVID-19 Vaccines
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-15A Randomized, Double-blind, Parallel-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E (Alpha/Beta/Delta/Omicron Variants S-Trimer COVID-19 Vaccine) in Population Aged ≥18 Years
-
CLINICAL_TRIALS study record update · 2024-04-08Mobile PCR-based Surveillance for SARS-CoV-2 to Reduce Visiting Restrictions in Nursing Homes During the COVID-19 Pandemic
-
CLINICAL_TRIALS study record update · 2024-04-08A Phase 1/2a Trial of the Intravenous Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c in SARS-CoV-2-Infected and -Uninfected Individuals
-
CLINICAL_TRIALS study record update · 2024-03-27Safety and Pharmacokinetics of Human Convalescent Plasma in High Risk Children Exposed or Infected With SARS-CoV-2
-
CLINICAL_TRIALS study record update · 2024-03-26Anesthetic Experience and Patients 'Prognosis of SARS-CoV-2 Positive Versus Negative Burns Patients: An Observational Case -Control Study
-
CLINICAL_TRIALS study record update · 2024-03-26Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19
-
CLINICAL_TRIALS study record update · 2024-03-25Antiviral Efficacy and Acceptability of Therapeutic Antiseptic Mouth Rinses for Inactivation of COVID SARS-2 Virus
-
CLINICAL_TRIALS study record update · 2024-03-13Better Understanding Physical and Cognitive Impairments and Functional Limitations in People Suffering From Long COVID to Support the Development of Adapted Interventions
-
CLINICAL_TRIALS study record update · 2024-03-06The Association Between Tobacco Use and COVID-19 Infection and Adverse Outcomes in Three Nordic Countries: a Pooled Analysis
-
CLINICAL_TRIALS study record update · 2024-03-06Randomized Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19
-
CLINICAL_TRIALS study record update · 2024-02-12First-in-human Trial of the Coronavirus Virus-like Particle Subunit Vaccine ABNCoV2 in SARS-CoV-2-naïve Adult Volunteers in Good Health
-
CLINICAL_TRIALS study record update · 2024-02-09A Phase 1, Dose Ranging Study Assessing the Safety, Tolerability, Immunogenicity of Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV-2 Spike and Nucleocapsid Proteins (ORFEUS Study)
-
CLINICAL_TRIALS study record update · 2024-02-09A Randomized, Double-blinded, Active-controlled Phase II Clinical Study to Evaluate the Immunogenicity and Safety of SCTV01C (A Bivalent SARS-CoV-2 Trimeric Spike Protein Vaccine) and SCTV01E (A COVID-19 Alpha/Beta/Delta/Omicron Variants S-Trimer Vaccine) in Population Aged ≥12 Years and Previously Unvaccinated
-
CLINICAL_TRIALS study record update · 2024-01-25Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients. Turkey Cohort, Prospective, Observational, Comparative Study
-
CLINICAL_TRIALS study record update · 2023-12-26NIRVANA: NIcotinamide Riboside in SARS-CoV-2 pAtients for reNAl Protection
-
CLINICAL_TRIALS study record update · 2023-12-04Short and Long Term Assessment of Lung Function, Exercise Capacity and Health-Related Quality of Life in Survivors of Severe COVID-19
-
CLINICAL_TRIALS study record update · 2023-12-01Phase 2 Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients With Respiratory Distress Due to COVID-19 Infection
-
CLINICAL_TRIALS study record update · 2023-11-24A PHASE 3, RANDOMIZED, OBSERVER-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF BNT162b2 WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE (SIIV) IN ADULTS 18 THROUGH 64 YEARS OF AGE
-
CLINICAL_TRIALS study record update · 2023-11-24SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents in Belgium
-
CLINICAL_TRIALS study record update · 2023-11-15The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.